Invention Grant
![Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR](/docs/US/2021-06-22/US11040979B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR
-
Application No.: US16498762Application Date: 2018-03-29
-
Publication No.: US11040979B2Publication Date: 2021-06-22
- Inventor: Brian L. Hodous , Joseph L. Kim , Kevin J. Wilson
- Applicant: Blueprint Medicines Corporation
- Applicant Address: US MA Cambridge
- Assignee: Blueprint Medicines Corporation
- Current Assignee: Blueprint Medicines Corporation
- Current Assignee Address: US MA Cambridge
- Agency: McCarter & English, LLP
- Agent Steven G. Davis; Wei Song
- International Application: PCT/US2018/025193 WO 20180329
- International Announcement: WO2018/183712 WO 20181004
- Main IPC: A61K31/5025
- IPC: A61K31/5025 ; C07D487/04
![Substituted pyrrolo[1,2-b]pyridazines for treating disorders related to KIT and PDGFR](/abs-image/US/2021/06/22/US11040979B2/abs.jpg.150x150.jpg)
Abstract:
Compounds and compositions useful for treating disorders related to KIT and PDGFR are described herein.
Public/Granted literature
Information query
IPC分类:
